These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 653637)

  • 21. [A young male mongrel with hemophilia-B (Christmas disease)].
    Kooistra HS; Slappendel RJ
    Tijdschr Diergeneeskd; 1991 Mar; 116(6):281-5. PubMed ID: 2028457
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preparation of factor IX deficient plasma by immunoadsorption using monoclonal antibody (3A6) to factor IX and its application].
    Nishimura T; Ohkubo Y; Nishino M; Sakai T; Sawai J; Tanaka I; Takamiya O; Yoshioka A
    Rinsho Byori; 1986 Apr; 34(4):469-74. PubMed ID: 3528584
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 24. Factor IX-inhibitors. Report of two cases and a study of the biological, chemical and immunological properties of the inhibitors.
    Lechner K
    Thromb Diath Haemorrh; 1971 Jun; 25(3):447-59. PubMed ID: 5561957
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A; Cella G; Patrassi G
    Haematologica; 1974 Mar; 59(1):91-108. PubMed ID: 4212668
    [No Abstract]   [Full Text] [Related]  

  • 27. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous canine FIX antigen exists in Chapel Hill strain hemophilia B canine.
    Chao H; Walsh CE
    Thromb Haemost; 1999 Oct; 82(4):1378. PubMed ID: 10544943
    [No Abstract]   [Full Text] [Related]  

  • 30. A rare case of an acquired inhibitor to factor IX.
    Krishnamurthy P; Hawche C; Evans G; Winter M
    Haemophilia; 2011 Jul; 17(4):712-3. PubMed ID: 21371188
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B.
    Thompson AR
    Thromb Res; 1977 Aug; 11(2):193-203. PubMed ID: 905971
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemophilia B Leyden].
    Briët E; van Leeuwen-Cornelisse IS; van der Vlerk D; van Tilburg NH
    Ned Tijdschr Geneeskd; 1986 Jul; 130(29):1324-7. PubMed ID: 3748213
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring of modified factor VIII and IX products.
    Kitchen S; Gray E; Mertens K
    Haemophilia; 2014 May; 20 Suppl 4():36-42. PubMed ID: 24762273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dentition restoration in hemophilia under substitution of AHG concentrates].
    Tetsch P; Esser E
    Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700
    [No Abstract]   [Full Text] [Related]  

  • 35. Variants of haemophilia B.
    Elödi S; Puskás E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):489-95. PubMed ID: 4675270
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired factor IX inhibitor in a patient with Christmas disease: case report.
    Riyat MS; Kasili EG; Omondi BE
    East Afr Med J; 1984 Feb; 61(2):159-62. PubMed ID: 6468323
    [No Abstract]   [Full Text] [Related]  

  • 37. Unintended benefit of anabolic steroid use in hemophilia B leiden.
    Rimmer EK; Seftel MD; Israels SJ; Houston DS
    Am J Hematol; 2012 Jan; 87(1):122-3. PubMed ID: 22038733
    [No Abstract]   [Full Text] [Related]  

  • 38. Time dependent factor IX inhibitor.
    Sarode R; Chauhan AP; Joseph M; Marwaha N; Sharma SK; Dash S
    Thromb Haemost; 1989 Dec; 62(4):1151. PubMed ID: 2559489
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of canine factor IX.
    Sugahara Y; Catalfamo J; Brooks M; Hitomi E; Bajaj SP; Kurachi K
    Thromb Haemost; 1996 Mar; 75(3):450-5. PubMed ID: 8701406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of EDTA in the electroimmunoassay of factor IX antigen in warfarin-treated patients.
    Yang HC
    Thromb Res; 1979; 15(1-2):89-94. PubMed ID: 113906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.